AU2002359474A1 - MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE - Google Patents

MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE

Info

Publication number
AU2002359474A1
AU2002359474A1 AU2002359474A AU2002359474A AU2002359474A1 AU 2002359474 A1 AU2002359474 A1 AU 2002359474A1 AU 2002359474 A AU2002359474 A AU 2002359474A AU 2002359474 A AU2002359474 A AU 2002359474A AU 2002359474 A1 AU2002359474 A1 AU 2002359474A1
Authority
AU
Australia
Prior art keywords
mbms
modifiers
methods
branching morphogenesis
morphogenesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002359474A
Other languages
English (en)
Other versions
AU2002359474A8 (en
Inventor
Felix D. Karim
Linda Nolan Keyes
Gregory D. Plowman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exelixis Inc
Original Assignee
Exelixis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis Inc filed Critical Exelixis Inc
Publication of AU2002359474A8 publication Critical patent/AU2002359474A8/xx
Publication of AU2002359474A1 publication Critical patent/AU2002359474A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/70—Invertebrates
    • A01K2227/706—Insects, e.g. Drosophila melanogaster, medfly
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Physiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002359474A 2001-11-26 2002-11-25 MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE Abandoned AU2002359474A1 (en)

Applications Claiming Priority (21)

Application Number Priority Date Filing Date Title
US33337901P 2001-11-26 2001-11-26
US33337401P 2001-11-26 2001-11-26
US33337101P 2001-11-26 2001-11-26
US33334301P 2001-11-26 2001-11-26
US60/333,371 2001-11-26
US60/333,343 2001-11-26
US60/333,374 2001-11-26
US60/333,379 2001-11-26
US33454201P 2001-11-30 2001-11-30
US33454501P 2001-11-30 2001-11-30
US33451501P 2001-11-30 2001-11-30
US33453701P 2001-11-30 2001-11-30
US33454001P 2001-11-30 2001-11-30
US60/334,545 2001-11-30
US60/334,515 2001-11-30
US60/334,542 2001-11-30
US60/334,537 2001-11-30
US60/334,540 2001-11-30
US33827601P 2001-12-05 2001-12-05
US60/338,276 2001-12-05
PCT/US2002/037777 WO2003045321A2 (fr) 2001-11-26 2002-11-25 Mbm en tant que modificateurs de morphogenese par ramification et procedes d'utilisation

Publications (2)

Publication Number Publication Date
AU2002359474A8 AU2002359474A8 (en) 2003-06-10
AU2002359474A1 true AU2002359474A1 (en) 2003-06-10

Family

ID=27581241

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002359474A Abandoned AU2002359474A1 (en) 2001-11-26 2002-11-25 MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE

Country Status (2)

Country Link
AU (1) AU2002359474A1 (fr)
WO (1) WO2003045321A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8105785B2 (en) 2003-06-19 2012-01-31 Exelixis, Inc. Mylks as modifiers of branching morphogenesis and methods of use
WO2005072470A2 (fr) * 2004-01-28 2005-08-11 Exelixis, Inc Genes mbm en tant que modificateurs de la morphogenese de ramification et methodes d'utilisation
GB0404929D0 (en) * 2004-03-04 2004-04-07 Inpharmatica Ltd Protein
JP4191189B2 (ja) * 2005-12-08 2008-12-03 康生 梅津 がん関連遺伝子活性化能を有するペプチド
NZ590631A (en) 2006-09-21 2011-12-22 Probiodrug Ag Novel genes related to glutaminyl cyclase
US8889709B2 (en) 2006-09-21 2014-11-18 Probiodrug Ag Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions
US9277737B2 (en) 2006-09-21 2016-03-08 Probiodrug Ag Mouse models carrying a knock-out mutation of the QPCTL-gene
US20120070444A1 (en) * 2007-01-19 2012-03-22 Probiodrug Ag IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS
GB201011819D0 (en) * 2010-07-14 2010-09-01 King S College London Neurodegenerative disorders
US9447193B2 (en) * 2013-03-24 2016-09-20 Development Center For Biotechnology Methods for suppressing cancer by inhibition of TMCC3

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420526B1 (en) * 1997-03-07 2002-07-16 Human Genome Sciences, Inc. 186 human secreted proteins
US6013787A (en) * 1999-02-23 2000-01-11 Isis Pharmaceuticals Inc. Antisense modulation of Smad4 expression

Also Published As

Publication number Publication date
WO2003045321A3 (fr) 2004-02-26
AU2002359474A8 (en) 2003-06-10
WO2003045321A2 (fr) 2003-06-05

Similar Documents

Publication Publication Date Title
AU2003220586A1 (en) Game piece and system and method of use
AU2002306768A1 (en) Expression profiles and methods of use
AU2002314466A1 (en) Withasol and methods of use
AU2002350289A1 (en) Polysaccharide biomaterials and methods of use thereof
AU2003259735A1 (en) Small-mer compositions and methods of use
AU2002359512A1 (en) Belts and methods of use thereof
AU2003299441A1 (en) Nf-hev compositions and methods of use
AU2002359474A1 (en) MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE
AU2002359476A1 (en) MAP4Ks AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2003284324A1 (en) Ccr8 as modifier of branching morphogenesis and methods of use
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2002362020A1 (en) CRBs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHOD OF USE
AU2002350245A1 (en) Mhyps as modifiers of branching morphogenesis and methods of use
EP1664337A4 (fr) Genes mbm en tant que modificateurs de la morphogenese ramifiee et leurs procedes d'utilisation
AU2003272449A1 (en) MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE
AU2003248881A1 (en) Snrks as modifiers of chk and branching morphogenesis and methods of use
AU2002355432A1 (en) Kavalactone compositions and methods of use
AU2002364195A1 (en) Plant msh2 sequences and methods of use
AU2003274911A1 (en) Mrbs as modifiers of the rb pathway and methods of use
WO2003016502A9 (fr) Tramdorines et procede d'utilisation de tramdorines
EP1664288A4 (fr) Gene mylk utilise en tant que modificateur de la morphogenese ramifiee et procedes d'utilisation correspondant
AU2002359696A1 (en) Vps41s as modifiers of cell death and methods of use
AU2003294499A1 (en) Rhebs as modifiers of the rb pathway and methods of use
EP1578945A3 (fr) Cct6 utilises comme modificateurs de la voie rb, et procedes d'utilisation correspondants

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase